An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin

Anthony Barnett, M Dreyer, P Lange, M Serdarevic-Pehar

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)446-446
Number of pages1
JournalDiabetes Care
Issue number2
Publication statusPublished - 1 Feb 2007

Cite this